An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease

NCT02566889 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
53
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated due to the inability to enroll a sufficient number of the required subject population

Conditions

Interventions

Sponsor

Janssen Scientific Affairs, LLC